CN1007249B - 2-苯基吡喃并[2，3-b]吡啶类化合物的制备方法 - Google Patents
2-苯基吡喃并[2，3-b]吡啶类化合物的制备方法Info
- Publication number
- CN1007249B CN1007249B CN85109303A CN85109303A CN1007249B CN 1007249 B CN1007249 B CN 1007249B CN 85109303 A CN85109303 A CN 85109303A CN 85109303 A CN85109303 A CN 85109303A CN 1007249 B CN1007249 B CN 1007249B
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- pyridine
- dihydro
- compound
- pyrans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US663,020 | 1984-10-19 | ||
| US06/663,020 US4588733A (en) | 1984-10-19 | 1984-10-19 | 2-phenylpyrano[2,3-b]pyridines and their use in inhibiting viruses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN85109303A CN85109303A (zh) | 1986-08-20 |
| CN1007249B true CN1007249B (zh) | 1990-03-21 |
Family
ID=24660185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN85109303A Expired CN1007249B (zh) | 1984-10-19 | 1985-10-17 | 2-苯基吡喃并[2，3-b]吡啶类化合物的制备方法 |
Country Status (22)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034531A (en) * | 1988-12-23 | 1991-07-23 | Schering Corporation | Fused polycyclic pyranyl compounds as antiviral agents |
| WO1993017682A1 (en) * | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Angiotensin ii receptor antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3518273A (en) * | 1966-08-03 | 1970-06-30 | Warner Lambert Pharmaceutical | Benzopyranquinolinol derivatives and process for their production |
| PL214115A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1978-03-15 | 1980-06-16 | Wellcome Found | |
| DE3069830D1 (en) * | 1979-09-13 | 1985-01-31 | Wellcome Found | Benzopyran compounds, useful as chemotherapeutic agents |
| US4801593A (en) * | 1979-09-13 | 1989-01-31 | Burroughs Wellcome Co. | Chemotherapeutic agents |
| US4563468A (en) * | 1979-09-13 | 1986-01-07 | Burroughs Wellcome Co. | Chemotherapeutic agents |
| US4371537A (en) * | 1981-08-13 | 1983-02-01 | The Dow Chemical Company | Sulfur-substituted phenoxypyridines having antiviral activity |
-
1984
- 1984-10-19 US US06/663,020 patent/US4588733A/en not_active Expired - Lifetime
-
1985
- 1985-10-14 NZ NZ213814A patent/NZ213814A/en unknown
- 1985-10-14 ZA ZA857872A patent/ZA857872B/xx unknown
- 1985-10-15 DE DE8585113077T patent/DE3585128D1/de not_active Expired - Fee Related
- 1985-10-15 AU AU48588/85A patent/AU576906B2/en not_active Ceased
- 1985-10-15 CA CA000492979A patent/CA1294282C/en not_active Expired - Lifetime
- 1985-10-15 AT AT85113077T patent/ATE71379T1/de active
- 1985-10-15 EP EP85113077A patent/EP0178633B1/en not_active Expired - Lifetime
- 1985-10-16 KR KR1019850007615A patent/KR900004214B1/ko not_active Expired
- 1985-10-16 NO NO854110A patent/NO162908C/no not_active IP Right Cessation
- 1985-10-16 FI FI854026A patent/FI83520C/fi not_active IP Right Cessation
- 1985-10-17 CN CN85109303A patent/CN1007249B/zh not_active Expired
- 1985-10-17 AR AR85301972A patent/AR242956A1/es active
- 1985-10-17 ES ES547983A patent/ES8703873A1/es not_active Expired
- 1985-10-17 PT PT81329A patent/PT81329B/pt not_active IP Right Cessation
- 1985-10-17 JP JP60230070A patent/JPH064633B2/ja not_active Expired - Lifetime
- 1985-10-17 HU HU854021A patent/HU193350B/hu not_active IP Right Cessation
- 1985-10-18 GR GR852532A patent/GR852532B/el unknown
- 1985-10-18 DK DK478685A patent/DK161328C/da not_active IP Right Cessation
- 1985-10-18 IE IE259085A patent/IE58145B1/en not_active IP Right Cessation
- 1985-10-21 PH PH32951A patent/PH23586A/en unknown
- 1985-10-22 IL IL76776A patent/IL76776A/xx not_active IP Right Cessation
-
1986
- 1986-09-12 ES ES557062A patent/ES8801283A1/es not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2691393B1 (en) | Novel bicyclic pyridinones | |
| EP2262804B1 (fr) | Dérivés polysubstitues de 6-heteroaryle-imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique | |
| US20070099991A1 (en) | Selective rxr ligands | |
| JPH0586953B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| TW200413345A (en) | Novel benzodioxoles | |
| DE3882642T2 (de) | Substituierte tetraline, chromane und verwandte verbindungen fuer die behandlung von asthma, arthritis und verwandte krankheiten. | |
| NO812558L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oksazolidin-derivater. | |
| MXPA06004344A (es) | Alcanaminas de dihidrobenzofuranilo y metodos para usar los mismos como agentes del sistema nervioso central. | |
| EA032314B1 (ru) | Трициклические гетероциклические соединения, применимые в качестве ингибиторов tnf | |
| CN1322206A (zh) | 作为细胞毒性抗肿瘤剂的萘并噻吩和二氢苯并噻吩的衍生物 | |
| JPS60224685A (ja) | 置換ベンゾピラン類、その製造法及びその用途 | |
| WO2001044187A1 (fr) | Nouveaux composes tricycliques substitues | |
| CN1007249B (zh) | 2-苯基吡喃并[2，3-b]吡啶类化合物的制备方法 | |
| CN1064966C (zh) | 具有5－ht受体亲和性的稠合噻唑衍生物 | |
| EP0420570A2 (en) | Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis | |
| JP2013151488A (ja) | 機能性ポリフェノール誘導体の化学合成法 | |
| EP3085695A1 (en) | Substituted triazinone compound and t-type calcium channel inhibitor | |
| Bargar et al. | 3, 4‐Dihydro‐2‐phenyl‐2H‐pyrano [2, 3‐b] pyridines. Novel aza analogs of flavans | |
| US8048898B2 (en) | Inhibitor of binding of S1P1 | |
| Zhou et al. | Deconstructive Cycloaromatization Strategy towards N, O-Bidentate Ligands and Their Four-Coordinate Organoboron Complexes | |
| CN108602834B (zh) | 一种布鲁顿酪氨酸激酶抑制剂 | |
| JP2023509180A (ja) | ３位がアミドアルキル基で置換されたクマリン系化合物の製造方法、その生成物及び関連中間体 | |
| HK40008377B (en) | 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases | |
| HK1016969A (en) | Novel substituted tetrahydropyrano [3,2-d) oxazolones, method for their preparation and pharmaceutical compositions containing them | |
| JPH07157480A (ja) | ジベンゾシクロオクタン誘導体およびこれを有効成分とするアルドースリダクターゼ阻害剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C13 | Decision | ||
| GR02 | Examined patent application | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CX01 | Expiry of patent term |